Mark J. Levin, Director at MILLENNIUM PHARMACEUTICALS INC (MLNM), sold 9,100 shares at $15.62 ($143K) on 2007-12-12, disclosed to the SEC on 2007-12-13.
Scheduled sale ($143k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.51 | 300 | $5K | 3.3% |
| 2 | $15.52 | 300 | $5K | 3.3% |
| 3 | $15.55 | 200 | $3K | 2.2% |
| 4 | $15.60 | 200 | $3K | 2.2% |
| 5 | $15.61 | 100 | $2K | 1.1% |
| 6 | $15.62 | 300 |
| $5K |
| 3.3% |
| 7 | $15.63 | 300 | $5K | 3.3% |
| 8 | $15.64 | 600 | $9K | 6.6% |
| 9 | $15.66 | 500 | $8K | 5.5% |
| 10 | $15.67 | 100 | $2K | 1.1% |
| 11 | $15.68 | 1,000 | $16K | 11.0% |
| 12 | $15.69 | 400 | $6K | 4.4% |
| 13 | $15.70 | 700 | $11K | 7.7% |
| 14 | $15.71 | 500 | $8K | 5.5% |
| 15 | $15.72 | 600 | $9K | 6.6% |
| 16 | $15.73 | 300 | $5K | 3.3% |
| 17 | $15.74 | 700 | $11K | 7.7% |
| 18 | $15.75 | 100 | $2K | 1.1% |
| 19 | $15.77 | 100 | $2K | 1.1% |
| 20 | $15.79 | 400 | $6K | 4.4% |
| 21 | $15.80 | 200 | $3K | 2.2% |
| 22 | $15.81 | 100 | $2K | 1.1% |
| 23 | $15.82 | 100 | $2K | 1.1% |
| 24 | $15.83 | 400 | $6K | 4.4% |
| 25 | $15.84 | 100 | $2K | 1.1% |
| 26 | $15.87 | 100 | $2K | 1.1% |
| 27 | $15.88 | 100 | $2K | 1.1% |
| 28 | $15.91 | 100 | $2K | 1.1% |
| 29 | $15.97 | 100 | $2K | 1.1% |
| 30 | $16.00 | 100 | $2K | 1.1% |
| Total | $15.70 avg | 9,100 | $143K | 100% |
| Filing → |
| MLNM | SELL | 2008-01-10 | $29K | — | Filing → |
| MLNM | SELL | 2008-01-10 | $122K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $120K | — | Filing → |